Executive Director Dr. Tido von Schoen-Angerer, calls for innovative funding mechanisms for global health in the Huffington Post. read more
Inauguration of the European Parliament Working Group on Innovation & Access in Brussels read more
U.S. health care legislation could limit access read more
MSF responds to World Health Organisation’s new HIV treatment guidelines read more
MSF sends letter to EU Ministers of Health regarding antibiotic resistance read more
MSF Access Campaign signs joint declaration on the threat of EU trade policy on accessibility to essential medicines read more
World Food Summit fails to address childhood malnutrition read more
MSF leads WTO workshop on medicine detainment by customs... read more
The cost of HIV medicines is rising all the time, meaning that many people with HIV will not be able to afford life-saving medicines. Unless……
There is a way to produce new drugs at affordable prices: Join us in pushing for the patent pool. This way drug companies share their drug patents with the pool, so they still get their royalities... but at the same time other companies, such as generic drug manufacturers and research institutions, can get hold of these patents to make cheaper drugs. Everyone wins.
Over 300,000 messages of support help realise creation of UNITAID’s patent pool
Thanks in no small part to the participation of thousands of individuals in the Make It Happen Campaign, UNITAID has announced the creation of the Patent Pool for AIDS medicines. The success of this campaign would not have been possible without your support, thank you!!
To read the rest of our update, click here.
To find out what happened over the course of the Make It Happen Campaign, how many people joined the Campaign, what countries participated in the push for the patent pool next, what events were held , and what the drug companies said, and more, click here.
Competition between different companies is the best way to make drugs more affordable. You can make sure competition happens by using the law to limit or overcome the barriers that stand in the way of generic competition; companies can also help build a new way to create drugs at affordable prices: by participating in the patent pool.
We need HIV drugs that will keep patients alive longer: Newer, better antiretrovirals are already used by patients in the US and Europe, but aren’t available to people in developing countries or are simply too expensive. We need these newer drugs, with fewer side effects, to gradually replace older treatments. Plus, as everyone on long-term treatment will eventually develop resistance to the drugs they are taking, all patients will at some point need to switch treatments, to newer drugs that continue to fight the HIV virus. By making these drugs more affordable, a patent pool will ensure the delivery of these newer drugs for people in the developing world. Make It Happen!
We need three-in-one HIV drugs that are easier to take: Treating HIV is complex and often requires patients to take multiple drug cocktails. But by combining the different drugs into one easy-to-take pill, patients are more likely to stick to their treatment. At the moment, it’s a struggle for generic producers to develop these much needed fixed-dose combinations, because different companies own the patents of the various drugs. By putting these patents under collective management, a patent pool will make it possible for many more combination therapies to be developed. Make It Happen!
We need HIV drugs for children: Two million children are living with HIV but less than 10 per cent of them have access to the medicines they need. All too often, there are no child formulations for drugs, as drug companies don’t have the incentive to develop them when the overwhelming majority of children in need live in developing countries. By putting HIV drug patents in the pool, we remove one of the barriers blocking the development of child formulated drugs and drug combinations. Make It Happen!
| AnimationsWatch these animations that explain how a patent pool could deliver the medicines we need. |
| VideosWatch these videos to hear from AIDS patients and their needs for improved access to HIV medications and better understand the need for a patent pool. |
Click here to learn more about the companies, the drugs they produce, and why we want them in the pool.
To see the list of combination therapies a patent pool could help produce, click here.
Find out more how drug resistance develops and the need for newer drugs, click here for more information.
For more background on patents, the problems they cause, and how they can be overcome, click here.
Find out about other ways of overcoming patent barriers to medicines, click here.
View previously featured news and information on patent pools here.
Last updated: December 14, 2009
Missing ARVs for HIV/AIDS treatment in 2009: Unitaid Patent Pool Briefing ![]()
HIV/AIDS treatment in developing countries: the battle for long-term survival has just begun ![]()
Untangling the Web of antiretroviral price reductions - Upcoming 12th Edition Pre-publication price analysis July 2009 ![]()
MSF Clinical Officer Olesi Ellemani Pasulani's reflections on AIDS treatment in Malawi
Living with MDR TB: 'Expert Client' Nonkululeko Mamba's Story
MDR TB Treatment in Cambodia: A Catalyst for Change